DARS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.366000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.400400E-01
Normal-vs-Stage2
4.558800E-01
Normal-vs-Stage3
3.111800E-01
Normal-vs-Stage4
2.887400E-01
Stage1-vs-Stage2
9.949800E-01
Stage1-vs-Stage3
1.794010E-01
Stage1-vs-Stage4
5.872000E-01
Stage2-vs-Stage3
8.844000E-02
Stage2-vs-Stage4
4.278200E-01
Stage3-vs-Stage4
8.363700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.608400E-01
Normal-vs-AfricanAmerican
6.646000E-02
Normal-vs-Asian
7.167600E-01
Caucasian-vs-AfricanAmerican
1.256010E-01
Caucasian-vs-Asian
7.817600E-01
AfricanAmerican-vs-Asian
3.181800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.625400E-01
Normal-vs-Female
5.179200E-01
Male-vs-Female
8.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.173200E-01
Normal-vs-Age(41-60Yrs)
4.852600E-01
Normal-vs-Age(61-80Yrs)
5.931800E-01
Normal-vs-Age(81-100Yrs)
3.510800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.633200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.597200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.794800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.346200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.065600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.769800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.464800E-01
Normal-vs-Daily Drinker
8.912000E-01
Normal-vs-Weekly Drinker
5.364000E-01
Normal-vs-Occasional Drinker
4.601600E-01
Normal-vs-Social Drinker
4.468600E-01
Non Drinker-vs-Daily Drinker
2.619600E-01
Non Drinker-vs-Weekly Drinker
9.733400E-01
Non Drinker-vs-Occasional Drinker
8.557800E-01
Non Drinker-vs-Social Drinker
6.732200E-01
Daily Drinker-vs-Weekly Drinker
3.317400E-01
Daily Drinker-vs-Occasional Drinker
3.075600E-01
Daily Drinker-vs-Social Drinker
1.659450E-01
Weekly Drinker-vs-Occasional Drinker
8.928800E-01
Weekly Drinker-vs-Social Drinker
6.911800E-01
Occasional Drinker-vs-Social Drinker
5.462800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.906200E-01
Normal-vs-Grade 2
2.546200E-01
Normal-vs-Grade 3
1.710830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.994300E-02
Grade 1-vs-Grade 3
4.284200E-03
Grade 1-vs-Grade 4
5.906200E-01
Grade 2-vs-Grade 3
2.560400E-02
Grade 2-vs-Grade 4
2.546200E-01
Grade 3-vs-Grade 4
1.710830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.844600E-01
Normal-vs-NonDiabetic
5.182800E-01
Diabetic-vs-NonDiabetic
3.273200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.224200E-01
Normal-vs-NoPancreatitis
5.563800E-01
Pancreatitis-vs-NoPancreatitis
5.731800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.264000E-01
Normal-vs-N1
4.942800E-01
N0-vs-N1
8.074200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.552630E-01
Normal-vs-TP53-NonMutant
4.997600E-01
TP53-Mutant-vs-TP53-NonMutant
1.569540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
